Alteryx price target lowered to $65 from $80 at Oppenheimer

Oppenheimer analyst Ittai Kidron lowered the firm’s price target on Alteryx to $65 from $80 and keeps an Outperform rating on the shares. Alteryx reported Q1 revenue/ARR roughly in line with expectations, and with strong KPIs, but weaker demand and worsening deal dynamics led to a miss on Q2 expectations, the analyst tells investors in a research note.